Heterogeneous Co@NC catalysts were prepared, characterized and applied for the general synthesis of secondary and tertiary amines by Co-catalyzed reductive amination with H2 gas.
Heterogeneous iridium catalysts were prepared and applied for the reductive amination of aldehydes and ketones with nitroaromatics and amines using H2. The iridium catalysts were prepared by pyrolysis of ionic liquid 1‐methyl‐3‐cyanomethylimidazoulium chloride ([MCNI]Cl) with iridium chloride (IrCl3) in activated carbons. Iridium particles were well dispersed and stable in the N‐doped carbon materials from [MCNI]Cl with activated carbon. The Ir@NC(600‐2h) catalyst was found to be highly active and selective for the reductive amination of aldehydes and ketones using H2 and a variety of nitrobenzenes and amines were selectively converted into the corresponding secondary and tertiary amines. The Ir@NC(600‐2h) catalyst can be reusable several times without evident deactivation.
The inside cover picture shows secondary and tertiary amines, which are important intermediates in organic synthesis for the preparation of natural products, pharmaceutical and agronomical compounds. The direct reductive amination of aldehydes and ketones represents a powerful tool for the preparation of secondary and tertiary amines. Here, direct and general reductive amination of aldehydes and ketones with amines and nitroaromatics was presented under H2 using recyclable iridium catalysts, and lots of secondary and tertiary amines were produced in high yields. Moreover, the heterogeneous iridium catalysts Ir@NC(600‐2h) can be reused several times without evident deactivation. More details are discussed in the article by Huang et al. on page 1371–1377.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.